Terry Roemer
Impact in
- Infectious Diseases top 0.5%
- Antifungal resistance and susceptibility
- Molecular Medicine top 2%
Papers in
-
- Fungal and yeast genetics research 17
- RNA and protein synthesis mechanisms 7
-
- Antifungal resistance and susceptibility 17
- Antimicrobial Resistance in Staphylococcus 11
- Co-authors
- Damian J. Krysan (1 shared paper)Howard Bussey (10 shared papers)Bo Jiang (9 shared papers)M Snyder (4 shared papers)Charles Boone (2 shared papers)Susan Sillaots (6 shared papers)Troy Ketela (3 shared papers)Deming Xu (11 shared papers)
- Journals
- PLoS Pathogens (4 papers)Journal of Natural Products (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Proceedings of the National Academy of Sciences (3 papers)Nature Chemical Biology (3 papers)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Terry Roemer
56 papers receiving 4.6k citations
Terry Roemer's Hit Papers
Peers
Comparison fields: 5 of 108
- Infectious Diseases 1.6k
- Molecular Medicine 269
- Microbiology 272
- Molecular Biology 2.9k
- Pharmacology 673
Countries citing papers authored by Terry Roemer
This map shows the geographic impact of Terry Roemer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry Roemer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry Roemer more than expected).
Fields of papers citing papers by Terry Roemer
This network shows the impact of papers produced by Terry Roemer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry Roemer. The network helps show where Terry Roemer may publish in the future.
Co-authors
The 25 scholars most cited alongside Terry Roemer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches Hit paper breakdown → | 2014 | 427 |
| 2 | 1999 | 409 | |
| 3 | 2003 | 385 | |
| 4 | 1997 | 324 | |
| 5 | 2007 | 189 | |
| 6 | 2007 | 186 | |
| 7 | 2015 | 183 | |
| 8 | 1994 | 124 | |
| 9 | 1996 | 120 | |
| 10 | 2011 | 118 | |
| 11 | 1991 | 117 | |
| 12 | 2013 | 111 | |
| 13 | 2010 | 107 | |
| 14 | 2012 | 103 | |
| 15 | 2013 | 97 | |
| 16 | 2008 | 93 | |
| 17 | 1993 | 92 | |
| 18 | 2011 | 83 | |
| 19 | 2012 | 77 | |
| 20 | 2015 | 77 |
About Terry Roemer
Terry Roemer is a scholar working on Molecular Biology, Infectious Diseases, Pharmacology, Plant Science and Epidemiology, having authored 56 papers that have together received 4.6k indexed citations. Recurring topics across this work include Fungal and yeast genetics research (17 papers), Antifungal resistance and susceptibility (17 papers), Microbial Natural Products and Biosynthesis (14 papers), Antimicrobial Resistance in Staphylococcus (11 papers), Bacterial Genetics and Biotechnology (10 papers), Fungal Infections and Studies (9 papers), Antibiotic Resistance in Bacteria (7 papers) and RNA and protein synthesis mechanisms (7 papers). The work is most often cited by research in Infectious Diseases (1.6k citations), Molecular Medicine (269 citations), Microbiology (272 citations), Molecular Biology (2.9k citations) and Pharmacology (673 citations). Terry Roemer has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Damian J. Krysan, Howard Bussey, Bo Jiang, M Snyder, Charles Boone, Susan Sillaots, Troy Ketela, Deming Xu, John Davison and Sébastien Lemieux. Their work appears in journals such as PLoS Pathogens, Journal of Natural Products, Bioorganic & Medicinal Chemistry Letters, Proceedings of the National Academy of Sciences and Nature Chemical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.